u/cormac_erdogan

Spain: 8 month NHS wait, gave up, went private, cost was pricing monthly.

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

I love that this community will spend 40 comments on a detail. That pedantry is why the numbers here matter.

Yeah, baseline matters more than any later number.

Mechanistically the bit that matters is pharmacy. It explains most of the early profile and a decent chunk of the outcome.

ALT is where the fatty-liver story shows up first

Do you have baseline to compare to?

Yeah, the network selection matters most.

Yeah, the NHS waitlist is genuinely two years in most places.

The confident tone is doing a lot of work that the evidence is not.

EU rules is usually a national question wearing a hat

Apotheke or receta or what?

Which network and did the vendor confirm they credit it?

no price talk, no tickers, no investment discussion

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

This is correct. Private and NHS pathways are different.

Half-life is about 168 hours, so steady state lands around week 24–5. Practical consequence: what you feel in week 1 is not what that dose does.

This is the "correlation is mechanism" thing again. You changed three variables at once.

You have restated the marketing copy. What is the actual substance here.